A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
Clinical trial NCT01664000 · COMPLETED
Trial details
- NCT number
- NCT01664000
- Sponsor
- Cellceutix Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.